Emergent BioSolutions Participates in Upcoming International Preparedness Conferences

Emergent BioSolutions (NYSE: EBS) said members of its products, medical affairs, government and public affairs teams will participate in four international preparedness conferences in April–June 2026.

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) said members of its products, medical affairs, government and public affairs teams will participate in four international preparedness conferences in April–June 2026.

Conferences listed include London Defence Conference (April 10–11), CBRN Research & Innovation (May 19–21), Global Health Security (June 9–12) and BIO International Convention (June 20–22). The company emphasized collaboration with governments on medical countermeasures for threats such as smallpox, anthrax, botulism and Ebola.

Argus Apr 2 session

-1.79% close to close Open Argus

Details

News Market Reaction – EBS

In the Apr 2 session, EBS declined 1.79%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines EBS’s participation in several international preparedness and health secu...

Analysis

This announcement outlines EBS’s participation in several international preparedness and health security conferences, emphasizing its role in biodefense and medical countermeasures against threats such as smallpox, anthrax, botulism and Ebola. In recent months, the company reported sizeable government contracts and a new $50M repurchase program, alongside a 2025 turnaround with $742.9M in revenue. Investors may watch for how these visibility efforts translate into future contracts and sustained operational performance.

Key Figures

London Defence Conference dates: April 10-11 CBRN Conference dates: May 19-21 Global Health Security Conf. dates: June 9-12 +1 more

London Defence Conference dates

April 10-11

London Defence Conference 2026

CBRN Conference dates

May 19-21

CBRN Research & Innovation Conference 2026

Global Health Security Conf. dates

June 9-12

Global Health Security Conference 2026

BIO Convention dates

June 20-22

BIO International Convention 2026

Historical Context

5 past events · Latest: Mar 25

5 events

1. Mar 25

   Government contracts

   24h Move

   -1.6%

   Over $60M in U.S. and international smallpox countermeasure contracts.

2. Mar 03

   Board appointment

   24h Move

   -0.8%

   Appointment of John D. Fowler Jr. to the board and audit committee.

3. Feb 26

   Earnings results

   24h Move

   -26.6%

   Q4 and FY2025 results with $742.9M revenue and $52.6M net income.

4. Feb 26

   Share repurchase

   24h Move

   -26.6%

   New $50M stock repurchase program replacing prior authorization.

5. Feb 26

   Government contracts

   24h Move

   -26.6%

   Canadian contracts and modification valued up to ~CAD 140M.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

cbrn, biodefense, medical countermeasures

3 terms

cbrn technical

"CBRN Research & Innovation Conference, May 19-21, Arcachon, France"

CBRN stands for chemical, biological, radiological and nuclear hazards and describes the kinds of dangerous agents and incidents that require specialized detection, protection, cleanup and medical responses. For investors, CBRN matters because companies that make protective equipment, detection systems, vaccines, cleanup services or insurance can see significant revenue, regulatory scrutiny and contract opportunities tied to preparedness and response capacity—think of it like investing in firms that sell unique locks and alarms for very rare but high‑impact break‑ins.

biodefense medical

"a global life sciences leader with biodefense and medical countermeasures products"

Biodefense is the set of tools, technologies and services designed to detect, prevent or respond to biological threats such as infectious diseases, engineered pathogens or accidental releases. For investors it signals a market focused on diagnostics, vaccines, protective gear, and rapid response systems — similar to an alarm-and-firefighting network for biological risks — which can drive revenue growth, government contracts and regulatory scrutiny depending on outbreak risks and public policy priorities.

medical countermeasures medical

"developing, manufacturing and delivering medical countermeasures to governments"

Medical countermeasures are the vaccines, drugs, diagnostics, protective gear and other treatments used to prevent, detect or treat public health threats such as infectious disease outbreaks or chemical exposures. Think of them as a community’s medical toolkit or fire extinguisher for emergencies; they matter to investors because demand can spike quickly during crises, draw government contracts and funding, and influence a company’s revenue, regulatory risk and long-term valuation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GAITHERSBURG, Md., April 02, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a global life sciences leader with biodefense and medical countermeasures products, announced today that members of its products business, medical affairs, government and public affairs teams will participate in the following international preparedness conferences:

• London Defence Conference, April 10-11, London, United Kingdom
• CBRN Research & Innovation Conference, May 19-21, Arcachon, France
• Global Health Security Conference, June 9-12, Kuala Lumpur, Malaysia
• BIO International Convention, June 20-22, San Diego, California, United States
  
  

“As the world navigates an increasingly complex health threat landscape, Emergent is committed to working with governments to help protect regional and global security,” said Paul Williams, senior vice president, head of products business, global government and public affairs. “We look forward to engaging with government and industry leaders to discuss how together we can strengthen preparedness and help protect and save lives.”

Emergent specializes in developing, manufacturing and delivering medical countermeasures to governments around the world for security and preparedness. These products support emergency response preparedness and help protect the public from critical threats like smallpox, anthrax, botulism and Ebola. Learn more about how we help protect people worldwide from biological threats at emergentbiosolutions.com/biothreats.

About Emergent BioSolutions 
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify. 

Investor Contact: 
Richard S. Lindahl 
Executive Vice President, CFO
lindahlr@ebsi.com 

Media Contact: 
Assal Hellmer 
Vice President, Communications 
mediarelations@ebsi.com 

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Which conferences will Emergent BioSolutions (EBS) attend in April–June 2026?

Emergent will attend four preparedness conferences between April and June 2026. According to the company, scheduled events are London Defence Conference (April 10–11), CBRN Research & Innovation Conference (May 19–21), Global Health Security Conference (June 9–12), and BIO International Convention (June 20–22).

Will Emergent BioSolutions (EBS) present at the BIO International Convention on June 20–22, 2026?

The company said its teams will participate at BIO International Convention on June 20–22, 2026. According to the company, staff from products, medical affairs, and government/public affairs will engage with industry and government leaders during the San Diego event.

How does Emergent BioSolutions (EBS) describe the purpose of attending these conferences?

Emergent says participation aims to strengthen preparedness and collaboration with governments. According to the company, meetings will focus on medical countermeasures and policy dialogue to protect regional and global security against biological threats.

Which medical threats does Emergent BioSolutions (EBS) cite in its conference participation announcement?

The company named smallpox, anthrax, botulism and Ebola as examples of threats addressed by its products. According to the company, its medical countermeasures support emergency response preparedness and help protect the public from critical biological threats.